SEARCH · PubMed Health
Results for “SARCOMA, FIBROSARCOMA”
Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
[Means of improving the diagnosis of malignant neoplasms of the soft tissues].
Explore the source record for details and available documents.
Bone case of the month: fibrosarcoma.
Explore the source record for details and available documents.
[Experimental immunotherapy of chemically induced fibrosarcomas in the mouse through active immunization].
Explore the source record for details and available documents.
Normal & malignant tissues--an investigation by pulsed nuclear magnetic resonance.
Explore the source record for details and available documents.
[Inhibition of a blastomatous process in bones by artificial hyperestrinism].
Explore the source record for details and available documents.
Murine splenic changes in response to syngeneic and allogeneic neoplasias.
Explore the source record for details and available documents.
Cellular phosphorylation of 1-beta-D-arabinofuranosylcytosine 5-azacytidine with intact fibrosarcoma and leukemic cells.
The phosphorylation of 1-beta-D-arabinofuranosylcytosine (ara-C) and 5-azacytidine (5-aza-C) by A(T1)C1-3 hamster fibrosarcoma cells and L5178Y murine leukemic cells was studied, using intact cells. The cellular phosphorylation of both these nucleoside analogs appears to follow Michaelis-Menton kinetics. The apparent Km value for ara-C in the fibrosarcoma and leukemic cells was about 40 muM, whereas the apparent Km values for 5-aza-C in these cells were about 1.3 and 0.41 mM, respectively. Deoxycytidine and cytidine were found to be potent competitive inhibitors of the phosphorylation of ara-C and 5-aza-C, respectively, ara-C and 5-aza-C were found to be weak competitive inhibitors of the phosphorylation of deoxycytidine and cytidine, respectively. A clone isolated from the fibrosarcoma cells that was partially resistant to the cytotoxic effects of ara-C exhibited a higher Km value for both ara-C and deoxycytidine than the wild-type fibrosarcoma cells.
Anticancer screening of SAN-AB: an extract of marking nut, Semecarpus anacardium.
Explore the source record for details and available documents.
Primary tumours of the chest wall.
Explore the source record for details and available documents.
[On the morphologic characteristics of chondrosarcoma and osteogenic sarcomas].
Explore the source record for details and available documents.
[Microangiographic findings in various malignant neoplasms of the limbs. Study of 20 cases].
Explore the source record for details and available documents.
Fine structural patterns in fibrosarcoma cells maintained in serial transplantation in Swiss albino mice.
Explore the source record for details and available documents.
[Thyroid sarcoma. Morphologic and histogenetic study. Clinical contribution].
Explore the source record for details and available documents.
The tourniquet technique in radiotherapy of limb tumours.
Explore the source record for details and available documents.
Diffusible cytotoxic substances and cell-mediated resistance to syngeneic tumors: in vitro demonstration.
Explore the source record for details and available documents.
Malignant lesions masquerading as popliteal cysts. A report of three cases.
Explore the source record for details and available documents.
[Technics and results of lymph node transplantation in experimental malignant tumors].
Explore the source record for details and available documents.